Brief introduction of GlaxoSmithKline Liang Hong Company
Hongliang, male, born in February, 1964 65438, a native of Beiliu, Guangxi, is a doctor and professor. He is also a doctoral supervisor of inorganic chemistry at Nankai University and Nanjing University and a doctoral supervisor of applied chemistry at Central South University. He is currently the deputy secretary and president of the Party Committee of Guangxi Normal University. Mainly engaged in the bio-inorganic chemistry research of serum albumin, the synthesis, structure and properties of molybdenum and transition metal complexes, and the inorganic chemistry research of natural drugs. In the past 10 years, he has presided over 1 pre-9731special research projects and participated in L projects; He has presided over more than 20 ministerial and provincial projects. * * * published more than 220 papers, including in angew.chem.int.ed, inorg.chem, crystal &; Growth design, CrystEngComm, dalton transportation. ,J. Inorg。 Biochemistry. More than 70 papers1were published in domestic and foreign journals such as China Science and Science Bulletin, which were cited by domestic and foreign scholars for more than 600 times. As the first person to complete, he won the first, second and third prizes of Guangxi Science and Technology Progress Award ***5; As the second and fourth finisher, he also won the third prize of Guangxi Science and Technology Progress Award and the second prize of Guangxi Science and Technology Progress Award 1 item; Obtained 2 national invention patents and applied for (accepted) 3 invention patents; As the first finisher, he won the first prize and the third prize of outstanding teaching achievements in Guangxi, and the third prize of outstanding achievements in social sciences in Guangxi1; As the third finisher, he won the second prize of Guangxi Excellent Teaching Achievement 1. 1996 was rated as "Excellent Expert of Guangxi Zhuang Autonomous Region" and enjoyed special allowance from the State Council in the same year. It was identified as the first-class and second-class candidate of the national "100 million talents project" and became the key training object of national cross-century academic and technical leaders. 1998 was identified as the first-class candidate of "Guangxi 100,000 Talents Project"; 1999 was awarded the title of "young and middle-aged expert with outstanding contributions from the state" and "outstanding professional and technical personnel in Guangxi Zhuang Autonomous Region"; 200 1 won the "China Youth Science and Technology Award"; In 2002, he won the third "Young College Teachers Award" from the Ministry of Education; In 2005, he was awarded the honorary title of "National Excellent Scientific and Technological Worker"; In 2008, he was awarded the "Outstanding Contribution Award for Western Development" by China Association for Science and Technology. In 2009, he won the honorary title of "the first outstanding scientific and technological talents in Guangxi universities". The main social part-time jobs are: director of Chinese Chemical Society, chairman of Guangxi Chemical and Chemical Society, editorial board of Inorganic Chemistry Journal (SCI-E), deputy editor of Guangxi Science, and invited international member of American Association for the Advancement of Science (AAAS). [1] research field: synthesis, properties and functions of metal-based drugs; Pharmacology and Pharmacokinetics of Metal-based Drugs: Study on the Structure and Function of protein: Research and development of metal-based drugs and biopharmaceutical carriers by applying bio-inorganic chemistry. In recent years, the main scientific research projects currently hosted by scientific research projects are: 1. National Natural Science Foundation of China (2 1 17 1043): Study on the Interaction between Antitumor Plants and Metal-based Drugs and Human Serum Albumin, 20 12.5438+0-20 15. 2. Pre-research topic of "973" plan (2007CB5 16805): Pre-research of new anti-tumor metal-based drugs based on active glycosides of traditional Chinese medicine produced in Guangxi, 2007/7-2008/12,856,500 yuan. 3. Project supported by the Regional Fund of the National Natural Science Foundation (30460 153): Study on the Material Basis and Action Mechanism of Medicinal Plants Endemic to Guangxi, 2005/1-2007/12.6 million yuan. 4. National Natural Science Foundation Project (2067 1023): Study on the Interaction between Serum Albumin and Metal Ions or Drugs in Abnormal Environment), 2007/1-2009/12.3 million yuan. 5. Preliminary research topic of "973" plan (2010cb534911): Preliminary research based on metal-based anti-tumor targeted drugs, effective components of Guangxi traditional Chinese medicine, 20 10/4-20 12/8. Innovation Team Project of Guangxi Natural Science Foundation (2010gxnsff013001): Research on natural or synthetic functional compounds, 2010/3-2013/32 million yuan. 7. Key project of Guangxi Natural Science Foundation (099 10 12Z): Study on the synthetic structure and anti-tumor activity of water-soluble metal complexes of Liriodendron chinense and shikimic acid, which are the effective components of traditional Chinese medicine in Guangxi, 2009/3-2012/3.3 million yuan.